Two Patients With Unusual Forms of Varicella-Zoster Virus Vasculopathy
NEJM 347:1500-1503, Gilden,D.H.,et al, 2002
Incidental Findings on Pediatric MR Images of the Brain
AJNR 23:1674-1677, Kim,B.S.,et al, 2002
Oral Anticoagulants vs Aspirin in Nonvalvular Atrial Fibrillation
JAMA 288:2441-2448, van Walraven,C.,et al, 2002
Acute Meningoencephalitis and Meningitis to Primary HIV Infection
BMJ 325:1225-1227, Newton,P.J.,et al, 2002
Late Secondary Ischemic Injury in Patients Receiving Intraarterial Thrombolysis
Ann Neurol 52:698-703,695, Kidwell,C.S.,et al, 2002
Phrenic Nerve Palsy Secondary to Lyme Neuroborreliosis
Neurol 59:1810-1811, Ishaq,S.,et al, 2002
Transient Ischemic Attack
NEJM 347:1687-1692, Johnston,S.C., 2002
Analysis of the Safety and Efficacy of Intra-Arterial Thrombolytic Therapy in Ischemic Stroke
Stroke 33:2866-2870, Lisboa,R.C.,et al, 2002
Intracerebral Hemorrhages Associated with Neurointerventional Procedures Using a Combination of Antithrombotic Agents Including Abciximab
Stroke 33:1916-1919, Qureshi,A.I.,et al, 2002
Low-Molecular-Weight Heparins or Heparinoids Versus Standard Unfarctionated Heparin for Acute Ischemic Stroke (Cochrane Review)
Stroke 33:1925-1926, Counsell,C. &Sandercock,P., 2002
Considering the Role of Heparin and Low-Molecular-Weight Heparins in Acute Ischemic Stroke
Stroke 33:1927-1933, Moonis,M. &Fisher,M., 2002
Response of Intra-Arterial and Combined Intravenous and Intra-Arterial Thrombolytic Therapy in Patients with Distal Internal Carotid Artery Occlusion
Stroke 33:1821-1826,1827, Zaidat,O.O,et al, 2002
Anticoagulants and Antiplatelet Agents in Acute Ischemic Stroke
Neurol 59:13-22, Coull,B.M.,et al, 2002
Transoesophageal Echocardiography in Selecting Patients for Anticoagulation After Ischaemic Stroke or Transient Ischaemic Attack
JNNP 73:29-33, Strandberg,M.,et al, 2002
Illness After International Travel
NEJM 347:505-516, Ryan,E.T.,et al, 2002
Poliomyelitis Due to West Nile Virus
NEJM 347:1280-1281, Glass,J.D.,et al, 2002
West Nile Virus Encephalitis
NEJM 347:1225-1226, Peterson,L.R.,et al, 2002
Safety of Tissue Plasminogen Activator for Acute Stroke in Menstruating Women
Stroke 33;2506-2508, Wein,T.H.,et al, 2002
Thrombolysis for Acute Stroke in Routine Clinical Practice
Arch Int Med 162:1994-2001, Bravata,D.M.,et al, 2002
Baseline Blood Pressure but Not Early Computed Tomography Changes Predicts Major Hemorrhage After Streptokinase in Acute Ischemic Stroke
Stroke 33:22236-2242, Gilligan,A.K.,et al, 2002
Arterial Reocclusion in Stroke Patients Treated with Intravenous Tissue Plasminogen Activator
Neurol 59:862-867, Alexandrov,A.V. &Grotta,J.C., 2002
Disease-Modifying Therapy in Multiple Sclerosis: Strategies for Optimizing Management
The Neurologist 8:227-236, Frohman,E.,et al, 2002
Correlation of Diffusion-Weighted Magnetic Resonance Imaging With Neuropathology in Creutzfeldt-Jakob Disease
Arch Neurol 59:128-134, Mittal,S.,et al, 2002
Magnetic Resonance Imaging Detection of Microbleeds Before Thrombolysis
Stroke 33:95-98, Kidwell,C.S.,et al, 2002
Sporadic CJD Clinically Mimicking Variant CJD With Bilateral Increased Signal in the Pulvinar
Neurol 58:148-149, Haik,S.,et al, 2002
An Outbreak of Eosinophilic Meningitis Caused by Angiostrongylus cantonensis in Travelers Returning from the Caribbean
NEJM 346:668-675, Slom,T.J.,et al, 2002
Gradient Echo Magnetic Resonance Imaging in the Prediction of Hemorrhagic vs Ischemic Stroke
Arch Neurol 59:425-429, Kim,D.,et al, 2002
Predictors of Hemorrhagic Transformation in Patients Receiving Intra-Arterial Thrombolysis
Stroke 33:717-724, Kidwell,C.S.,et al, 2002
Emergent Use of Anticoagulation for Treatment of Patients with Ischemic Stroke
Stroke 33:856-861, Adams,H.P., 2002
The Neurological Masquerade of Intravascular Lymphomatosis
Arch Neurol 59:439-443, Beristain,X.&Azzarelli,B., 2002
White Matter Hyperintensities and Neuropsychological Outcome Following Carbon Monoxide Poisoning
Neurol 58:1525-1532, Parkinson,R.B.,et al, 2002
Acute Basilar Artery Occlusion Treated with Combined Intravenous Abciximab and Intra-arterial Tissue Plaminogen Activator
Stroke 33:1424-1427, Eckert,B.,et al, 2002
Systemic lupus erythematosus Related Transverse Myelitis Presenting Longitudinal Involvement of the Spinal Cord
Intern Med 41:156-160, Kimura,K.Y.,et al, 2002
Neurological Involvement in Acute Q Fever
Arch Int Med 162:693-700, Bernit,E.,et al, 2002
Aseptic Meningitis Associated with Rofecoxib
Arch Int Med 162:713-715, Bonnel,R.A.,et al, 2002
Use of Intravenous Heparin by North American Neurologists
Stroke 33:1574-1577, Al-Sadat,A.,et al, 2002
Thrombolysis-Related Hemorrhagic Infarction
Stroke 33:1551-1556,1446, Molina,C.A.,et al, 2002
Warfarin-Aspirin Recurrent Stroke Study (WARSS) Trial
Stroke 33:1723-1726, Hankey,G.J., 2002
Aspirin Should be First-Line Antiplatelet Therapy in the Secondary Prevention of Stroke
Stroke 33:2137-2139, Warlow,C., 2002
Anthrax meningoencephalitis
Neurol 59:327-334,300, Lanska,D.J., 2002
West Nile Virus: A Primer for the Clinician
Ann Int Med 137:173-179, Petersen,L.R. &Marfin,A.A., 2002
Predictors of Hemorrhagic Transformation After Intravenous Recombinant Tissue Plasminogen Activator
Stroke 33:2047-2052, Selim,M.,et al, 2002
Compliance With Secondary Prevention of Ischemic Stroke
Stroke 32:1884-1889, Sappok,T.,et al, 2001
Optic Neuropathy in Children With Lyme Disease
Pediatrics 108:477-481, Rothermel,H.,et al, 2001
Risk Factors for Visual Loss in Giant Cell (Temporal) Arteritis:A Prospective Study of 174 Patients
Am J Med 111:211-217, Liozohn,E.,et al, 2001
Parenchymal Hyperdensity on Computed tomography after Intra-Arterial Reperfusion Therapy for Acugte Middle Cerebral Artery Occlusion,Incidence and Clinical Significance
Stroke 32:2042-2048, Nakano,S.,et al, 2001
Safety of Anticoagulation for Cerebral Venous Thrombosis Associated with Intracerebral Hematoma
Neurol 57:1138-1139, Fink,J.N.&McAuley,D.L., 2001
An ALS-Like Syndrome with New HIV Infection and Complete Response to Antiretroviral Therapy
Neurol 57:1094-1097,945, MacGowan,D.J.L.,et al, 2001
Reversible ALS-Like Disorder in HIV Infection
Neurol 57:995-1001,945, Moulignier,A.,et al, 2001
Risk of Stroke Associated With Abciximab Among Patients Undergoing Percutaneous Coronary Intervention
JAMA 286:78-82, Akkerhuis,K.M.,et al, 2001